During the hour-long program Preventing Prescription Abuse, hear from prevention and law enforcement leaders about what we can do to help prevent prescription drug abuse. See how takeback programs can help keep drugs from getting into the wrong hands. Find out how prescription drug monitoring programs are working in many states and how a center of excellence is working to improve them.
- Discover the overall scope of the prescription drug problem in the United States
- Learn where and how people get their medications
- See how medication takeback programs can help prevent abuse
- Hear how prescription monitoring programs differ
- Find out how education and awareness can help
Originally Aired: January 27, 2011
Chief of Prevention, Florida Office of Drug Control
The Office of Drug Control is a part of the Executive Office of the Governor and is charged with coordinating substance abuse prevention, treatment and law enforcement activities across state agencies, including the Department of Children and Families.
Prior to joining ODC, Goudy worked for the Florida Alcohol and Drug Abuse Association as their first statewide Director of Prevention. She was the executive director of The House Next Door, a Volusia County substance abuse prevention services provider. While working in Volusia County, Goudy chaired One Voice for Volusia, one of the largest coalitions in Florida. Goudy has also owned and operated a marketing and public relations company and an eco-tour company.
Goudy has a Bachelor of Arts in journalism from Marshall University.
Executive Director, National Association of Drug Diversion Investigators, NADDI
Charles (Charlie) Cichon is the executive director of the National Association of Drug Diversion Investigators (NADDI), a nonprofit organization that facilitates cooperation among law enforcement, health care professionals, state regulatory agencies and pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion.
Cichon brings a diverse background to this role, including his work in law enforcement, health regulatory agencies and the pharmaceutical industry. In addition to his role as executive director of NADDI, Cichon is also the program director for the National Precursor Log Exchange (NPLEx). NPLEx is a real-time electronic tracking program for pseudoephedrine, offered free to states as an effective alternative to legislation that eliminates over-the-counter pseudoephedrine products.
Prior to joining NADDI as the executive director in 1998, Cichon worked for Eli Lilly and Company in the role of brand protection representative for the Americas. Cichon also served as the chief compliance investigator for the Maryland Medical Board, and as a police officer with the Baltimore City Police in the Criminal Investigation Division.
He earned his bachelor’s degree in criminal justice from the University of Baltimore.